ReviewCytokine: X2021
Using CRISPR to enhance T cell effector function for therapeutic applications.
Julian J Freen-van HeerenPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it
ReviewCytokine: X2021
Julian J Freen-van HeerenPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.